Role of α1-adrenoceptor subtypes in production of the positive inotropic effects in mammalian myocardium: Implications for the α1- adrenoceptor subtype distribution

Life Sciences

Volumn 62, Issue 17-18, 1998, Pages 1449-1453

  Hattori, Yuichi ^a   Kanno, Morio ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

1 adrenoceptor subtype; Heart; Negative inotropic effect; Positive inotropic effect

Indexed keywords

2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; ALPHA 1 ADRENERGIC RECEPTOR; NORADRENALIN; PHENYLEPHRINE; RECEPTOR SUBTYPE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CARDIOTONIC AGENT; DIOXANE DERIVATIVE;

ANIMAL TISSUE; CALCIUM TRANSPORT; CONFERENCE PAPER; HEART INNERVATION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; INOTROPISM; MYOFILAMENT; NONHUMAN; RAT; RECEPTOR DENSITY; SYMPATHETIC INNERVATION; ACTION POTENTIAL; ANIMAL; CLASSIFICATION; DRUG EFFECT; HEART; HEART CONTRACTION; HEART MUSCLE; PHYSIOLOGY; REVIEW; ULTRASTRUCTURE;

ACTION POTENTIALS; ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; CARDIOTONIC AGENTS; DIOXANES; HEART; MYOCARDIAL CONTRACTION; MYOCARDIUM; PHENYLEPHRINE; RECEPTORS, ADRENERGIC, ALPHA-1;

EID: 0032571015     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00088-5     Document Type: Conference Paper

References (22)

1. 1. A. TERZIC, M. PUCÉAT, G. VASSORT and S.M. VOGEL, Pharmacol. Rev. 45 147-175 (1993).
2. 2. H.J. SCHÜMANN, M. ENDOH and O.E. BRODDE, Naunyn-Schmiedeberg's Arch. Pharmacol. 289 291-302 (1975).
3. 3. M. ENDOH and J.R. BLINKS, Circ. Res. 62 247-265( 1988).
4. 4. D. FEDIDA and R.A. BOUCHARD, Circ. Res. 71 673-688 (1992).
5. 5. A. TERZIC and S.M. VOGEL. J. Pharmacol. Exp. Ther. 257 520-529 (1991).
6. 6. K.P. MINNEMAN, Pharmacol. Rev. 40 87-119 (1988).
7. 7. J.P. HIEBLE, D.B. BYLUND, D.E. CLARKE, D.C. EIKENBURG, S.Z. LANGER, R.J. LEFKOWITZ, K.P. MINNEMAN and R.R. RUFFOLO, Jr., Pharmacol. Rev. 47 267-270 (1995).
8. 8. X.F. DENG, S. CHEMTOB and D.R. VARMA, Br. J. Pharmacol. 119 269-276 (1996).
9. 9. S.-N. WANG, H.J. FONTENOT and R.H. KENNEDY, Eur. J. Pharmacol. 321 39-43 (1997).
10. 10. M. TAKANASHI, I. NOROTA and M. ENDOH, Naunyn-Schmiedeberg's Arch. Pharmacol. 343 669-673 (1991).
11. 11. M. ENDOH, M. TAKANASHI and I. NOROTA, Naunyn-Schmiedeberg's Arch. Pharmacol. 345 578-585 (1992).
12. 12. M.C. MICHEL, G. HANFT and G. GROSS, Br. J. Pharmacol. 111 539-546 (1994).
13. 13. A.P. WILLIAMSON, E. SEIFEN, J.P. LINDEMANN and R.H. KENNEDY, Am. J. Physiol. 266 H2462-H2467 (1994).
14. 14. M.C. MICHEL, G. HANFT and G. GROSS, Br. J. Pharmacol. 111 533-538 (1994).
15. 15. Y. HATTORI, M. NAGASHIMA, Y. AKAISHI and M. KANNO, Res. Commun. Mol. Pathol. Pharmacol. 93 319-329 (1996).
16. 16. M. NAGASHIMA, Y. HATTORI, Y. AKAISHI, N. TOHSE, I. SAKUMA, A. KITABATAKE and M. KANNO, Am. J. Physiol. 271 H1423-H1432 (1996).
17. 17. N. TOHSE, H. NAKAYA, Y. HATTORI, M. ENDOU and M. KANNO, Pflügers Arch. 415 571-581 (1990).
18. 18. Y. HATTORI, Y. TAKEDA, H. NAKAYA and M. KANNO, Br. J. Pharmacol. 109 1232-1238 (1993).
19. 19. Y. HATTORI and M. KANNO, Eur. J. Pharmacol. 329 165-168 (1997).
20. 20. N. TOHSE, Y. HATTORI, H. NAKAYA and M. KANNO, Gen. Pharmacol. 18 539-546 (1987).
21. 21. M. ENDOU, Y. HATTORI, N. TOHSE and M. KANNO, Am. J. Physiol. 260 H27-H36 (1991).
22. 22. M. NAGASHIMA, Y. HATTORI, N. TOHSE and M. KANNO, Gen. Pharmacol. 28 721-725 (1997).